EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics

Dianjie Zeng iD, Bojian Liu, Fei Deng, Yinhuai Wang, Jiachen Liu iD, Zebin Deng

The Oncologist · 17.01.2026 · 31 (2)

DOI: 10.1093/oncolo/oyaf409 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 23.01.2026. Verfasst von Dianjie Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Xiangya Hospital at Central South University, Changsha 410011, Hunan, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Urinary Bladder Neoplasms, Exosomes, Circulating Tumor DNA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BCa), marked by clinical heterogeneity and late diagnosis, remains a global health challenge. The limitations of conventional diagnostics have spurred the advancement of liquid biopsy approaches, which offer minimally invasive tools for early detection, prognosis, and therapeutic monitoring. This review highlights key components of liquid biopsy in BCa, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes, and metabolomics—especially urinary volatile organic compounds (VOCs). Each modality contributes distinct insights into tumor biology: CTCs and ctDNA provide information on tumor genetics and dynamics; exosomes reflect microenvironmental signaling and lipid metabolism; and urinary VOC profiling enables metabolic characterization and early-stage discrimination. We explore how these dimensions complement each other in tracking disease progression, predicting recurrence, and guiding personalized therapy. Emphasis is placed on recent technological advances, clinical utility, and future integration into practice. This multidimensional perspective underscores the transformative potential of liquid biopsy in improving BCa outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingUrinary Bladder NeoplasmsExosomesCirculating Tumor DNAMetabolomicsHumansLiquid BiopsyBiomarkers, Tumor

Stichwörter der Autor:innen

bladder cancerexosomelipid metabolismliquid biopsytumor microenvironments

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The Second Xiangya Hospital at Central South University, Changsha 410011, Hunan, China.
  • Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, China.
  • Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Department of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, 410011, China.

ORCID-Profile: Dianjie Zeng, Jiachen Liu

Zitieren

APA

Zeng, D., Liu, B., Deng, F., Wang, Y., Liu, J., & Deng, Z. (2026). Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics. The Oncologist, 31(2). https://doi.org/10.1093/oncolo/oyaf409

Vancouver

Zeng D, Liu B, Deng F, Wang Y, Liu J, Deng Z. Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics. The Oncologist. 2026;31(2). doi:10.1093/oncolo/oyaf409

BibTeX
@article{Zeng2026,
  author = {Zeng, Dianjie and Liu, Bojian and Deng, Fei and Wang, Yinhuai and Liu, Jiachen and Deng, Zebin},
  title = {Multidimensional liquid biopsy in bladder cancer: advances in circulating tumor cells, circulating tumor DNA, exosomes, and metabolomics},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {2},
  doi = {10.1093/oncolo/oyaf409}
}
Kostenlos starten →